The Hunan Provincial Respiratory Drug Engineering Technology Research Center was established in 2013 with the approval of the Hunan Provincial Science and Technology Department, exclusively organized by Hunan Jiudian Pharmaceutical Co., Ltd. as the sole respiratory drug technology research and development platform in Hunan Province. The establishment of this center represents not only an enhancement of the company's own capabilities but also aligns with the national talent strategy. The center adopts a research and development model that prioritizes independent research and development, complemented by cooperative development and technology introduction. It focuses on consolidating existing competitive products within its specialized series while supplementing potential product lines and continuously developing new drugs based on market demands. Simultaneously, the company continuously optimizes the production processes of existing products, enabling rapid transformation of new products and technologies into productive forces to meet market needs. Its leading products, Levocetirizine Dihydrochloride Capsules and Tablets, are respectively the first domestically and the second nationally to pass the consistency evaluation. Additionally, the company has also applied for Ebastine Tablets under the new drug registration classification (deemed to have passed the consistency evaluation). The Engineering Technology Research Center will serve as a solid foundation for the transformation, complementation, and engineering of respiratory drug technology achievements in our province. It embodies the integration of industry, academia, and research, serving as an incubator for new respiratory drugs and gradually evolving into a technologically advanced and fully functional scientific research and development platform.